Global Health · NSE: MEDANTA · BSE: 543654
Q1 FY26 results · Apr–Jun 2025
Global Health reported revenue from operations of ₹1,030.84 crore (up 19.7% from Q1 FY25) and net profit of ₹158.98 crore (up 49.6% from Q1 FY25) for Q1 FY26 (Apr–Jun 2025), on a consolidated basis.
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 1,030.84 | 861.08 | +19.7% | 931.25 | +10.7% |
| Other income | 20.46 | 21.93 | −6.7% | 22.93 | −10.8% |
| Total income | 1,051.29 | 883.00 | +19.1% | 954.18 | +10.2% |
| Profit before tax | 208.14 | 143.65 | +44.9% | 133.44 | +56.0% |
| Net profit for the period | 158.98 | 106.26 | +49.6% | 101.38 | +56.8% |
| Attributable to shareholders of the company | 159.01 | 106.29 | +49.6% | 101.40 | +56.8% |
| EPS, basic (₹) | 5.92 | 3.96 | +49.5% | 3.77 | +57.0% |
| Net margin (%) | 15.4 | 12.3 | 10.9 |
| Item | Q1 FY26 | Q1 FY25 | YoY | Q4 FY25 | QoQ |
|---|---|---|---|---|---|
| Revenue from operations | 882.16 | 611.45 | +44.3% | 802.87 | +9.9% |
| Other income | 23.14 | 26.70 | −13.3% | 25.67 | −9.8% |
| Total income | 905.29 | 638.15 | +41.9% | 828.53 | +9.3% |
| Profit before tax | 198.25 | 129.74 | +52.8% | 125.89 | +57.5% |
| Net profit for the period | 151.96 | 96.28 | +57.8% | 93.41 | +62.7% |
| EPS, basic (₹) | 5.66 | 3.58 | +58.1% | 3.48 | +62.6% |
| Net margin (%) | 17.2 | 15.7 | 11.6 |
Consolidated
- Filed with BSE
- 07 Aug 2025, 17:44 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE
Standalone
- Filed with BSE
- 07 Aug 2025, 17:44 IST
- Board meeting
- 07 Aug 2025
- Period
- 01 Apr 2025 to 30 Jun 2025
- Review status
- Unaudited
- Source
- XBRL filing on BSE